Эстония - эстонский - Ravimiamet

johnson & johnson uab - metüülfenidaat - toimeainet prolongeeritult vabastav tablett - 18mg 30tk; 18mg 28tk

Эстония - эстонский - Ravimiamet

johnson & johnson uab - metüülfenidaat - toimeainet prolongeeritult vabastav tablett - 54mg 30tk

Эстония - эстонский - Ravimiamet

medice arzneimittel puetter gmbh & co. kg - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 10mg 50tk; 10mg 30tk

Эстония - эстонский - Ravimiamet

zentiva k.s. - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 60mg 60tk; 60mg 28tk; 60mg 100tk; 60mg 50tk; 60mg 40tk; 60mg 56tk; 60mg 30tk

Эстония - эстонский - Ravimiamet

zentiva k.s. - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 40mg 28tk; 40mg 100tk; 40mg 50tk

Эстония - эстонский - Ravimiamet

zentiva k.s. - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 20mg 84tk; 20mg 28tk; 20mg 50tk; 20mg 56tk; 20mg 60tk; 20mg 30tk; 20mg 100tk

Эстония - эстонский - Ravimiamet

zentiva k.s. - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 30mg 50tk; 30mg 100tk; 30mg 60tk; 30mg 56tk

Эстония - эстонский - Ravimiamet

zentiva k.s. - metüülfenidaat - toimeainet modifitseeritult vabastav kõvakapsel - 10mg 56tk; 10mg 50tk; 10mg 100tk; 10mg 60tk; 10mg 28tk

Эстония - эстонский - Ravimiamet

colep laupheim gmbh & co. kg - metüülsalitsülaat+levomentool+eukalüptiõli+tärpentiniõli - kreem - 128mg+59,1mg+19,7mg+14,7mg 1g 15g 1tk

Европейский союз - эстонский - EMA (European Medicines Agency)

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.